Literature DB >> 20729452

Preoperative MRI evaluation of pituitary macroadenoma: imaging features predictive of successful transsphenoidal surgery.

Jerrold L Boxerman1, Jeffrey M Rogg, John E Donahue, Jason T Machan, Marc A Goldman, Curt E Doberstein.   

Abstract

OBJECTIVE: The purpose of this study was to determine whether the preoperative MRI findings of enhanced diffusivity, macrocyst content, and internal hemorrhage in pituitary macroadenomas are predictive of successful transsphenoidal hypophysectomy.
MATERIALS AND METHODS: We retrospectively reviewed the preoperative and postoperative sella protocol MR images of 28 patients who underwent transsphenoidal hypophysectomy for chiasm-compressing macroadenoma. Chiasmatic decompression defined surgical success. Two neuroradiologists differentiated nonsolid (macrocystic and macrohemorrhagic) from solid tumors, computed apparent diffusion coefficient (ADC) and T2-weighted signal intensity normalized to pons in solid tumors, and measured change in tumor height. A neuropathologist graded reticulin content in tumor specimens. Categorical and dichotomous variables were examined with the chi-square or Fisher's exact test; continuous-scale data were analyzed with the Student's t test, analysis of variance, or linear regression.
RESULTS: Transsphenoidal hypophysectomy succeeded in the management of 10 of 11 nonsolid tumors and nine of 17 solid tumors (p = 0.049). The ratios of tumor to brainstem ADC in the nine successfully resected solid tumors were higher than in the eight cases of failed treatment (p = 0.008) with no significant difference in ratio of tumor to brainstem T2-weighted signal intensity (p = 0.76). All six solid tumors with enhanced diffusivity (ratio of tumor to brainstem ADC > 1.1) were successfully managed with transsphenoidal hypophysectomy, compared with three of 11 with an ADC ratio less than 1.1 (p = 0.009). There was a significant main effect of ADC ratio groupings on change in tumor height (p = 0.02), and a linear relation was found between ADC ratio and change in tumor height (p = 0.04). Taken together, tumors with nonsolid features or an ADC ratio greater than 1.1 were highly resectable (p < 0.001; sensitivity, 0.84; specificity, 0.89). ADC ratios in reticulin-poor solid tumors were higher than those in reticulin-rich tumors (p = 0.024).
CONCLUSION: Macrocystic and macrohemorrhagic adenomas and solid tumors with enhanced diffusivity are more likely to be successfully managed with transsphenoidal hypophysectomy. Transsphenoidal hypophysectomy of solid, enhancing tumors with restricted diffusion is more likely to fail, possibly because of the greater reticulin content of the tumor; initial transcranial surgery may be appropriate in these cases.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20729452     DOI: 10.2214/AJR.09.4128

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  26 in total

1.  Accuracy of diffusion-weighted imaging-magnetic resonance in differentiating functional from non-functional pituitary macro-adenoma and classification of tumor consistency.

Authors:  Morteza Sanei Taheri; Farnaz Kimia; Mersad Mehrnahad; Hamidreza Saligheh Rad; Hamidreza Haghighatkhah; Afshin Moradi; Anahita Fathi Kazerooni; Mohammadreza Alviri; Abdorrahim Absalan
Journal:  Neuroradiol J       Date:  2018-12-03

2.  Evaluation of diffusivity in the anterior lobe of the pituitary gland: 3D turbo field echo with diffusion-sensitized driven-equilibrium preparation.

Authors:  A Hiwatashi; T Yoshiura; O Togao; K Yamashita; K Kikuchi; K Kobayashi; M Ohga; S Sonoda; H Honda; M Obara
Journal:  AJNR Am J Neuroradiol       Date:  2013-07-18       Impact factor: 3.825

3.  Diffusion-weighted imaging for predicting tumor consistency and extent of resection in patients with pituitary adenoma.

Authors:  Wei Ding; Zheng Huang; Gaofeng Zhou; Lang Li; Mingyu Zhang; Zhenyan Li
Journal:  Neurosurg Rev       Date:  2021-01-28       Impact factor: 3.042

4.  Predictive role of dynamic contrast enhanced T1-weighted MR sequences in pre-surgical evaluation of macroadenomas consistency.

Authors:  Andrea Romano; Valeria Coppola; Mariangela Lombardi; Luigi Lavorato; Domenica Di Stefano; Emanuela Caroli; Maria Camilla Rossi Espagnet; Francesca Tavanti; Giuseppe Minniti; Giuseppe Trillò; Alessandro Bozzao
Journal:  Pituitary       Date:  2017-04       Impact factor: 4.107

5.  Apparent diffusion coefficient and pituitary macroadenomas: pre-operative assessment of tumor atypia.

Authors:  Benita Tamrazi; Melike Pekmezci; Mariam Aboian; Tarik Tihan; Christine M Glastonbury
Journal:  Pituitary       Date:  2017-04       Impact factor: 4.107

6.  Relationship between postoperative volume of macroadenomas and clinical outcome after endoscopic trans-sphenoidal resection.

Authors:  Valeria Onofrj; Carina Vallejo; Paulo Puac; Carlos Zamora; Mauricio Castillo
Journal:  Neuroradiol J       Date:  2018-08-09

7.  Tumor to Cerebellar Peduncle T2-Weighted Imaging Intensity Ratio Fails to Predict Pituitary Adenoma Consistency.

Authors:  Panagiotis Mastorakos; Gautam U Mehta; Ajay Chatrath; Shayan Moosa; Maria-Beatriz Lopes; Spencer C Payne; John A Jane
Journal:  J Neurol Surg B Skull Base       Date:  2018-08-24

8.  Guidance value of MRI for transsphenoidal surgery of pituitary adenomas with cystic degeneration.

Authors:  Deyong Xiao; Shousen Wang; Lin Zhao; Liangfeng Wei; Jingfang Hong; Qun Zhong; Yinghao Yu; Yinxing Huang
Journal:  Int J Clin Exp Med       Date:  2015-04-15

9.  Incidental sinonasal findings identified during preoperative evaluation for endoscopic transsphenoidal approaches.

Authors:  Adrienne M Laury; Nelson M Oyesiku; Costas G Hadjipanayis; John M Delgaudio; Sarah K Wise
Journal:  Am J Rhinol Allergy       Date:  2013 May-Jun       Impact factor: 2.467

10.  Evaluation of diffusivity in pituitary adenoma: 3D turbo field echo with diffusion-sensitized driven-equilibrium preparation.

Authors:  Akio Hiwatashi; Osamu Togao; Koji Yamashita; Kazufumi Kikuchi; Makoto Obara; Takashi Yoshiura; Hiroshi Honda
Journal:  Br J Radiol       Date:  2016-05-17       Impact factor: 3.039

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.